Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 EUR | 0.00% | -1.12% | -20.51% |
04/04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/02 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.51% | 13.9M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+46.00% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Pauses Early-Stage Colorectal Cancer Trial Amid Safety Issues